vimarsana.com

Page 5 - தேசிய புற்றுநோய் மையம் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Deep Vision: Near-infrared imaging and machine learning can identify hidden tumors

 E-Mail IMAGE: The machine learning technique developed by Dr. Takemura and team could distinguish tumor tissue from healthy tissue in ex vivo images of resected tumors, with 86% accuracy. view more  Credit: Hiroshi Takemura from Tokyo University of Science Tumors can be damaging to surrounding blood vessels and tissues even if they re benign. If they re malignant, they re aggressive and sneaky, and often irrevocably damaging. In the latter case, early detection is key to treatment and recovery. But such detection can sometimes require advanced imaging technology, beyond what is available commercially today. For instance, some tumors occur deep inside organs and tissues, covered by a mucosal layer, which makes it difficult for scientists to directly observe them with standard methods like endoscopy (which inserts a small camera into a patient s body via a thin tube) or reach them during biopsies. In particular, gastrointestinal stromal tumors (GISTs) typically found in

Myriad Genetics Receives Reimbursement for BRACAnalysis® Diagnostic System in Japan

Myriad Genetics Receives Reimbursement for BRACAnalysis® Diagnostic System in Japan Font : A-A+ from Treatment with Lynparza More Than 20,000 Patients in Japan Now Qualify for Genetic Testing SALT LAKE CITY, Jan. 19, 2021 (GLOBE NEWSWIRE) In an announcement that will help more people with advanced prostate and pancreatic cancers in Japan, Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will receive reimbursement for its BRACAnalysis ® Diagnostic System, which helps physicians determine whether certain patients will qualify and potentially benefit from treatment with the PARP inhibitor, Lynparza (olaparib). BRACAnalysis was approved by Japan’s Ministry of Health, Labour and Welfare (MHLW) in October 2020 as a companion diagnostic for these indications and the reimbursement decision is now in effect.

Extremely Rare Phenomenon Sees Babies Inhale Cancer Cells During Vaginal Birth

Extremely Rare Phenomenon Sees Babies Inhale Cancer Cells During Vaginal Birth 14 JANUARY 2021 It s not impossible for an infant to get cancer from their mother, but it doesn t happen very often. Researchers estimate transmission of maternal cancer to offspring occurs perhaps only twice in every million births for mothers with cancer, with the diseased cells being delivered to the infant via the placenta in these exceedingly rare and unfortunate cases.   But that s not the only way a mother with cancer might unknowingly infect her child, scientists say. In a new case study published by researchers in Japan, doctors report what appears to be a medical first: vaginal transmission of cancer cells from mothers with cervical cancer to infants at the moment of their birth.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.